Chronic hepatitis B infection

Clinical trials for Chronic hepatitis B infection explained in plain language.

Never miss a new study

Get alerted when new Chronic hepatitis B infection trials appear

Sign up with your email to follow new studies for Chronic hepatitis B infection, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New hepatitis b drug shows promise in Mid-Stage trial

Disease control Ongoing

This Phase 2 study tests an experimental drug called ALG-000184 against a standard hepatitis B medication (tenofovir) in 200 adults with chronic hepatitis B. Participants take one pill daily for 48 weeks. The main goal is to see if the new drug can lower hepatitis B virus levels …

Matched conditions: CHRONIC HEPATITIS B INFECTION

Phase 2 • Sponsor: Aligos Therapeutics • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

Chronic hepatitis B infection

Get alerted when new Chronic hepatitis B infection trials appear

New hepatitis b drug shows promise in Mid-Stage trial